Venturi Group
3
5M
2
0.33
1
- Areas of investment
Summary
The main office of represented VC is situated in the Saint Paul. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, Mayo Clinic, MPM Capital. In the next rounds fund is usually obtained by Three Arch Partners, Mayo Clinic, MPM Capital.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight NBI Development, Nevro. Among the most successful fund investment fields, there are Medical Device, Biotechnology.
The top activity for fund was in 2006. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2014.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Health Diagnostics (2)
- Pharmaceutical (2)
- Biotechnology (2)
- Health Care (2)
- Manufacturing (1) Show 2 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Nevro | 04 Dec 2006 | Biotechnology, Health Care, Health Diagnostics, Pharmaceutical | Seed | 5M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.